Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Aug 30;453(1):198-214.
doi: 10.1016/j.ijpharm.2012.08.042. Epub 2012 Aug 25.

Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs

Ying Lu  1 , Kinam Park
Affiliations
Review

Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs

Ying Lu et al. Int J Pharm. .

Abstract

Poorly soluble drugs often encounter low bioavailability and erratic absorption patterns in the clinical setting. Due to the rising number of compounds having solubility issues, finding ways to enhance the solubility of drugs is one of the major challenges in the pharmaceutical industry today. Polymeric micelles, which form upon self-assembly of amphiphilic macromolecules, can act as solubilizing agents for delivery of poorly soluble drugs. This manuscript examines the fundamentals of polymeric micelles through reviews of representative literature and demonstrates possible applications through recent examples of clinical trial developments. In particular, the potential of polymeric micelles for delivery of poorly water-soluble drugs, especially in the areas of oral delivery and in cancer therapy, is discussed. Key considerations in utilizing polymeric micelles' advantages and overcoming potential disadvantages have been highlighted. Lastly, other possible strategies related to particle size reduction for enhancing solubilization of poorly water-soluble drugs are introduced.

Keywords: Anticancer; Clinical trial; Drug solubilization; Micelle stability; Nanocrystal; Nanoemulsion; Oral delivery; Polymeric micelle.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic representation of supramolecular structure of polymeric micelles.
Figure 2
Figure 2
Schematic summary of the pathways by which polymeric micelles may interact with the intestinal mucosa. A) receptor-mediated endocytosis; B) pinocytosis; C) Efflux of drug molecules
Figure 3
Figure 3
(A) Pharmacokinetic profile of DTXL-TNP in humans: A) comparison of plasma concentration time profile of DTXL-TNP at a dose of 30 mg/m2 compared to published sb-DTXL data at the same dose in patients with advanced solid tumors (n=3). (B) Plasma concentration time profile in dose-ranging studies over the first 8 hours after single dose administration of DTXL-TNP. (Figures adapted from Reference 96).
See this image and copyright information in PMC

References

    1. Lipinski C. Drug-like properties and the causes of poor solubility and poor permeability. Journal of Pharmacological and Toxicological Methods. 2000;44(1):235–249. - PubMed
    1. Merisko-Liversidge EM, Liversidge GG. Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds. Toxicologic Pathology. 2008;36(1):43–48. - PubMed
    1. Horter D, Dressman JB. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Advanced Drug Delivery Reviews. 2001;46(1-3):75–87. - PubMed
    1. Kawabata Y, Wada K, Nakatani M, Yamada S, Onoue S. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: Basic approaches and practical applications. International Journal of Pharmaceutics. 2011;420(1):1–10. - PubMed
    1. Kawakami K, Yoshikawa T, Moroto Y, Kanaoka E, Takahashi K, Nishihara Y, Masuda K. Microemulsion formulation for enhanced absorption of poorly soluble drugs: I. Prescription design. Journal of Controlled Release. 2002;81(1-2):65–74. - PubMed

Publication types